NCRI 2019: Non-invasive test for detecting cervical pre-cancer developed

Written by Jade Parker, Senior Editor

Researchers have developed self-screening test to detect pre-cancerous cervical lesions. The non-invasive test, termed S5, allows women to self collect urine and vaginal samples. Findings from the study were recently presented at the NCRI 2019 Cancer Conference (3-5 November, Glasgow, Scotland). In previous research, whereby the test accuracy was evaluated on samples collected by health care professionals it demonstrated a 100% accuracy rate at detecting invasive cervical cancer and 93% at detecting pre-cancer in women who had received a HPV positive test. The test works by analyzing DNA methylation of four HPV types most strongly associated with cancer – HPV16,...

To view this content, please register now for access

It's completely free